NYSE:CLB - Core Laboratories Stock Price, Forecast & News

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Core Laboratories announced a quarterly dividend on Wednesday, January 15th. Shareholders of record on Friday, January 24th will be paid a dividend of $0.25 per share on Friday, February 14th. This represents a $1.00 annualized dividend and a yield of 3.41%. The ex-dividend date is Thursday, January 23rd. View Core Laboratories' Dividend History.

Core Laboratories (NYSE:CLB) released its quarterly earnings data on Wednesday, January, 29th. The oil and gas company reported $0.38 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.37 by $0.01. The oil and gas company had revenue of $157 million for the quarter, compared to the consensus estimate of $155.31 million. Core Laboratories had a return on equity of 42.25% and a net margin of 15.26%. The firm's quarterly revenue was down 9.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.48 earnings per share. View Core Laboratories' Earnings History.

Core Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, April 22nd 2020. View Earnings Estimates for Core Laboratories.

Core Laboratories issued an update on its first quarter earnings guidance on Wednesday, January, 29th. The company provided EPS guidance of $0.39-0.41 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.39. The company issued revenue guidance of $159-164 million, compared to the consensus revenue estimate of $159.64 million.

13 Wall Street analysts have issued twelve-month price targets for Core Laboratories' stock. Their forecasts range from $36.00 to $77.00. On average, they anticipate Core Laboratories' share price to reach $47.86 in the next twelve months. This suggests a possible upside of 63.3% from the stock's current price. View Analyst Price Targets for Core Laboratories.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 9 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories.

News headlines about CLB stock have been trending neutral recently, InfoTrie Sentiment reports. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Core Laboratories earned a coverage optimism score of 0.0 on InfoTrie's scale. They also assigned press coverage about the oil and gas company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Core Laboratories.

Core Laboratories saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 3,660,000 shares, an increase of 29.3% from the January 15th total of 2,830,000 shares. Based on an average daily volume of 696,500 shares, the days-to-cover ratio is presently 5.3 days. Approximately 8.4% of the shares of the stock are sold short. View Core Laboratories' Current Options Chain.

Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), Oceaneering International (OII), Helix Energy Solutions Group (HLX), SemGroup (SEMG), NexTier Oilfield Solutions (NEX), Propetro (PUMP), Liberty Oilfield Services (LBRT), RPC (RES), Franks International (FI), National Energy Services Reunited (NESR), Select Energy Services (WTTR), Keane Group (FRAC), Hurricane Energy (HRCXF), North American Construction Group (NOA) and Natural Gas Services Group (NGS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Starbucks (SBUX), Micron Technology (MU), AT&T (T), Baidu (BIDU), NIC (EGOV) and Netflix (NFLX).

Core Laboratories' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (10.70%), Earnest Partners LLC (6.61%), Van ECK Associates Corp (5.67%), Kayne Anderson Rudnick Investment Management LLC (3.45%), Mairs & Power INC (2.28%) and Bank of New York Mellon Corp (1.74%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland, Kevin Daniels, Lawrence Bruno and Mark F Elvig. View Institutional Ownership Trends for Core Laboratories.

CLB stock was sold by a variety of institutional investors in the last quarter, including Granite Investment Partners LLC, Baird Financial Group Inc., Manning & Napier Group LLC, Kayne Anderson Rudnick Investment Management LLC, Eaton Vance Management, Schroder Investment Management Group, Penn Capital Management Co. Inc. and Evercore Wealth Management LLC. Company insiders that have sold Core Laboratories company stock in the last year include Kevin Daniels and Mark F Elvig. View Insider Buying and Selling for Core Laboratories.

CLB stock was purchased by a variety of institutional investors in the last quarter, including Van ECK Associates Corp, C Partners Holding GmbH, Thrivent Financial for Lutherans, Mairs & Power INC, Teacher Retirement System of Texas, Douglas Lane & Associates LLC, Bank of Montreal Can and Earnest Partners LLC. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett, Jan Willem Sodderland and Lawrence Bruno. View Insider Buying and Selling for Core Laboratories.

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CLB stock can currently be purchased for approximately $29.30.

Core Laboratories has a market capitalization of $1.30 billion and generates $668.21 million in revenue each year. The oil and gas company earns $101.98 million in net income (profit) each year or $1.79 on an earnings per share basis. Core Laboratories employs 4,300 workers across the globe.View Additional Information About Core Laboratories.

The official website for Core Laboratories is http://www.corelab.com/.

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]